UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
SCHEDULE
14A
Proxy
Statement Pursuant to Section 14(a) of the Securities
Exchange
Act of 1934
Filed
by the Registrant ☒
Filed
by a Party other than the Registrant ☐
Check
the appropriate box:
| ☐ |
Preliminary
Proxy Statement |
| ☐ |
Confidential,
for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
| ☐ |
Definitive
Proxy Statement |
| ☒ |
Definitive
Additional Materials |
| ☐ |
Soliciting
Material under § 240.14a-12 |
| CareCloud,
Inc. |
| (Name
of Registrant as Specified In Its Charter) |
| |
| |
| (Name
of Person(s) Filing Proxy Statement, if other than the Registrant) |
Payment
of Filing Fee (Check all boxes that apply):
| ☐ |
Fee
paid previously with preliminary materials. |
| |
|
| ☐ |
Fee
computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. |
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date
of Report (Date of earliest event reported): December 9, 2024
CARECLOUD,
INC.
(Exact
name of registrant as specified in its charter)
| Delaware |
|
001-36529 |
|
22-3832302 |
(State
or other jurisdiction
of incorporation) |
|
(Commission
File Number) |
|
(IRS
Employer
Identification No.) |
7
Clyde Road, Somerset, New Jersey, 08873
(Address of principal executive offices, zip code)
(732)
873-5133
(Registrant’s
telephone number, including area code)
Not
Applicable
(Former name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
| ☐ |
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
|
| ☐ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
|
| ☐ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
|
| ☐ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities
registered pursuant to Section 12(b) of the Act:
| Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which registered |
| Common
Stock, par value $0.001 per share |
|
CCLD |
|
Nasdaq
Global Market |
| 8.75%
Series A Cumulative Redeemable Perpetual Preferred Stock, par value $0.001 per share |
|
CCLDP |
|
Nasdaq
Global Market |
| 8.75%
Series B Cumulative Redeemable Perpetual Preferred Stock, par value $0.001 per share |
|
CCLDO |
|
Nasdaq
Global Market |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item
7.01 Regulation FD Disclosure.
On
December 9, 2024, the Registrant issued a press release announcing the commencement of the solicitation of proxies to approve
an amendment to the Registrant’s Certificate of Amendment of Amended and Restated Certificate of Incorporation (“Certificate
of Incorporation”). A copy of the press release is attached hereto as Exhibit 99.1 and incorporated
herein by reference.
On
December 9, 2024, the Registrant provided a slide presentation to accompany its proxy statement with respect to the solicitation
of proxies to approve an amendment to the Certificate of Incorporation. A copy of the slide presentation is attached hereto as Exhibit
99.2 and is incorporated herein by reference.
The
information furnished pursuant to Item 7.01 of this Form 8-K shall not be deemed “filed” for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that section,
nor shall it be deemed incorporated by reference into any other filing under the Securities Act of 1933, as amended or the Exchange Act,
except as expressly set forth by specific reference in such a filing.
Safe
Harbor Statement
Statements
contained in the exhibits that state the Registrant’s or its management’s expectations or predictions of the future are forward-looking
statements intended to be covered by the safe harbor provisions of the Securities Act of 1933, as amended, and the Securities Exchange
Act of 1934, as amended. It is important to note that the Registrant’s actual results could differ materially from those projected
in such forward-looking statements. The Registrant does not assume any obligations to update any of the forward-looking statements contained
in the exhibits to reflect events that occur or circumstances that exist after the date on which they were made.
Item
9.01 Financial Statements and Exhibits.
(d)
Exhibits
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
| |
|
CareCloud,
Inc. |
| |
|
|
| Date: |
December
9, 2024 |
By:
|
/s/ A. Hadi Chaudhry |
| |
|
|
A. Hadi Chaudhry |
| |
|
|
Chief Executive Officer |
Exhibit
99.1
CareCloud
Files Special Meeting Proxy to Accelerate Growth
SOMERSET,
N.J., December 9, 2024 (GLOBE NEWSWIRE) — CareCloud, Inc. (the “Company” or “CareCloud”) (Nasdaq:
CCLD CCLDO, CCLDP), a leader in healthcare information technology solutions for medical practices and health systems nationwide, today
announced the solicitation of proxies from its common stock (the “Common Stock”) shareholders to approve an increase in its
authorized shares. This increase is designed to support the Company’s growth initiatives and corporate objectives.
Focus
on Growth
Mahmud
Haq, Founder and Executive Chairman of CareCloud’s Board of Directors stated, “As CareCloud’s largest common stockholder,
Founder and Executive Chairman, I enthusiastically support this proposal. Our board and executive team collectively own more than 38%
of the Common Stock and we firmly believe that increasing the number of authorized shares is essential to driving our revenue and profits
– empowering us to deliver sustained, double-digit growth with a simultaneous, laser-like focus on profitability.”
CareCloud,
a leading developer and provider of healthcare information technology and AI solutions, has achieved a 23% compound annual growth rate
(“CAGR”) over the past decade through its focus on acquisitive and organic growth. During the first three quarters of 2024,
the Company generated over $10 million in free cash flow and achieved a 50% year-over-year increase in adjusted EBITDA.
The
Proposal
The
board-supported proposal seeks to increase the Company’s authorized shares of Common Stock from 35 million to 85 million. This
increase is intended to provide the flexibility needed for strategic growth initiatives, including future acquisitions, and to enable
the potential conversion of the Company’s outstanding Series A Preferred Stock to Common Stock. Additionally, it supports investments
in organic growth and other corporate priorities.
The
Special Meeting of Common Stock Shareholders, which is scheduled for January 27, 2025, will enable holders of the Common Stock as of
December 3, 2024 to vote on increasing the Company’s authorized shares of Common Stock. Additional information regarding the Proxy
is available on the Company’s website and at www.sec.gov.
How
to Vote
CareCloud
encourages all shareholders to participate and ensure their voices are heard. Shareholders may vote through one of the following methods:
| - | E-Vote:
Shareholders may visit the website of the Company’s transfer agent (https://www.vstocktransfer.com/proxy)
and use the identified control number to vote on or before 11:59 pm Eastern Time on January
23, 2025. Alternatively, they may vote online through their investment broker by following
their voting instructions. |
| - | Mail:
Shareholders may mark, sign and date their proxy card, then detach it, and return it in the
enclosed postage paid envelope. Proxies must be received by January 23, 2025, to be counted. |
| - | Attend
the Special Meeting: Shareholders may attend and vote their shares at the Special
Meeting on January 27, 2025. |
About
CareCloud
CareCloud
brings disciplined innovation to the business of healthcare. Our suite of technology-enabled solutions helps clients increase financial
and operational performance, streamline clinical workflows and improve the patient experience. More than 40,000 providers count on CareCloud
to help them improve patient care while reducing administrative burdens and operating costs. Learn more about our products and services
including revenue cycle management (RCM), practice management (PM), electronic health records (EHR), business intelligence, patient experience
management (PXM) and digital health at www.carecloud.com.
Follow
CareCloud on LinkedIn, Twitter and Facebook.
Important
Additional Information and Where to Find It. CareCloud filed with the SEC a Definitive Proxy Statement on Schedule 14A on December
5, 2024, with respect to its future solicitation of proxies for the Special Meeting of Common Stock Shareholders (including any and all
adjournments, postponements, continuations, and reschedulings thereof, the “Special Meeting”). The information contained
in this press release is merely a summary of certain relevant portions of the Definitive Proxy Statement and it is important that shareholders
review the entirety of the filing. SHAREHOLDERS ARE URGED TO READ THE DEFINITIVE PROXY STATEMENT AND ANY OTHER AMENDMENTS OR SUPPLEMENTS
FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY BECAUSE THEY CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION ABOUT CARECLOUD’S
FILING. Investors and security holders may obtain copies of these documents and other documents filed with the SEC by CareCloud free
of charge through the website maintained by the SEC at www.sec.gov. The Notice of the Special Meeting of Common Stock Shareholders
and our Definitive Proxy Statement for the Special Meeting, the Annual Report on Form 10-K for the fiscal year ended December 31, 2023
and our Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2024 are available at www.sec.gov.
Forward-Looking
Statements
This
press release contains various forward-looking statements within the meaning of the safe harbor provisions of the U.S. Private Securities
Litigation Reform Act of 1995. These statements relate to anticipated future events, future results of operations or future financial
performance. In some cases, you can identify forward-looking statements by terminology such as “may,” “might,”
“will,” “shall,” “should,” “could”, “intends,” “expects,” “plans,”
“goals,” “projects,” “anticipates,” “believes,” “seeks,” “estimates,”
“predicts,” “possible,” “potential,” “target,” or “continue” or the negative
of these terms or other comparable terminology.
Our
operations involve risks and uncertainties, many of which are outside our control, and any one of which, or a combination of which, could
materially affect our results of operations and whether the forward-looking statements ultimately prove to be correct. Forward-looking
statements in this press release include, without limitation, statements reflecting management’s expectations for future financial
performance and operating expenditures, expected growth, profitability and business outlook, the impact of pandemics on our financial
performance and business activities, and the expected results from the integration of our acquisitions.
These
forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are only predictions, are
uncertain and involve substantial known and unknown risks, uncertainties and other factors which may cause our (or our industry’s)
actual results, levels of activity or performance to be materially different from any future results, levels of activity or performance
expressed or implied by these forward-looking statements. New risks and uncertainties emerge from time to time, and it is not possible
for us to predict all of the risks and uncertainties that could have an impact on the forward-looking statements, including without limitation,
risks and uncertainties relating to the Company’s ability to manage growth, migrate newly acquired customers and retain new and
existing customers, maintain cost-effective global operations, increase operational efficiency and reduce operating costs, predict and
properly adjust to changes in reimbursement and other industry regulations and trends, retain the services of key personnel, develop
new technologies, upgrade and adapt legacy and acquired technologies to work with evolving industry standards, compete with other companies’
products and services competitive with ours, and other important risks and uncertainties referenced and discussed under the heading titled
“Risk Factors” in the Company’s filings with the Securities and Exchange Commission.
The
statements in this press release are made as of the date of this press release, even if subsequently made available by the Company on
its website or otherwise. The Company does not assume any obligations to update the forward-looking statements provided to reflect events
that occur or circumstances that exist after the date on which they were made.
SOURCE
CareCloud
Company
Contact:
Norman
Roth
Interim
Chief Financial Officer and Corporate Controller
CareCloud,
Inc.
nroth@carecloud.com
Investor
Contact:
Stephen Snyder
President
CareCloud,
Inc.
ir@carecloud.com
Exhibit
99.2
CareCloud (NASDAQ:CCLDP)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024
CareCloud (NASDAQ:CCLDP)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024
